Inhibition by dications of in vitro growth of Leishmania major and Leishmania tropica: Causative agents of old world cutaneous leishmaniasis

Journal of Parasitology

Volumn 94, Issue 3, 2008, Pages 743-749

  Rosypal, Alexa C ^a   Werbovetz, Karl A ^a,b   Salem, Manar ^a,b,c   Stephens, Chad E ^a,d,e   Kumar, Arvind ^a,d   Boykin, David W ^a,d   Hall, James E ^a   Tidwell, Richard R ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c Tanta University   (Egypt)

^d GEORGIA STATE UNIVERSITY   (United States)

^e AUGUSTA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,5 BIS(4 AMIDINOPHENYL)FURAN; AMIDINE; DB 103; DB 154; DB 181; DB 244; DB 545; DB 569; DB 613; DB 712; DB 714; DB 745; DB 746; DB 766; DB 785; DB 786; DB 811; DB 814; DB 99; FURAN DERIVATIVE; PENTAMIDINE;

ANTIBIOTICS; GROWTH RESPONSE; INHIBITION; LEISHMANIASIS; MICROBIAL ACTIVITY; MODELING; PROTOZOAN;

AMASTIGOTE; ANTIPROTOZOAL ACTIVITY; ARTICLE; DRUG CYTOTOXICITY; DRUG STRUCTURE; IC 50; LEISHMANIA MAJOR; NONHUMAN; PROMASTIGOTE; SKIN LEISHMANIASIS;

AMIDINES; ANIMALS; ANTIPROTOZOAL AGENTS; CELLS, CULTURED; FURANS; HUMANS; INHIBITORY CONCENTRATION 50; LEISHMANIA MAJOR; LEISHMANIA TROPICA; LEISHMANIASIS, CUTANEOUS; MALE; MYOBLASTS; PARASITIC SENSITIVITY TESTS; PENTAMIDINE; RATS;

LEISHMANIA MAJOR; LEISHMANIA TROPICA;

EID: 47349125360     PISSN: 00223395     EISSN: None     Source Type: Journal    
DOI: 10.1645/GE-1387R1.1     Document Type: Article

References (33)

1. AHMAD, K. 2002. War and gerbils compound Afghan leishmaniasis epidemic. Lancet 2: 268.
2. ANSEDE, J., M. ANBAZHAGAN, R. BRUN, J. EASTERBROOK, J. HALL, AND D. BOYKIN. 2004. O-alkoxyamidine prodrugs of furamidine: In vitro transport and microsomal metabolism as indicators of in vivo efficacy in a mouse model of Trypanosoma brucei rhodesiense infection. Journal of Medicinal Chemistry 47: 4335-4338.
3. BELL, C., M. CORY, T. FAIRLEY, J. HALL, AND R. TIDWELL. 1991. Structure-activity relationships of pentamidine analogs against Giardia lamblia and correlation of antigiardial activity with DNA-binding affinity. Antimicrobial Agents and Chemotherapy 35: 1099-1107.
4. _, J. E. HALL, D. E. KYLE, M. GROGL, K. A. OHEMENG, M. A. ALLEN, AND R. R. TIDWELL. 1990. Structure-activity relationships of analogs of pentamidine against Plasmodium falciparum and Leishmania mexicana amazonensis. Antimicrobial Agents and Chemotherapy 34: 1381-1386.
5. BLAGBURN, B. L., K. L. DRAIN, T. M. LAND, R. G. KINARD, P. H. MOORE, D. S. LINDSAY, D. W. BOYKIN, AND R. R. TIDWELL. 1998. Comparative efficacy evaluation of dicationic carbazole compounds, nitazoxanide, and paromomycin against Cryptosporidium parvum infections in a neonatal mouse model. Antimicrobial Agents and Chemotherapy 42: 2877-2882.
6. BLUM, J., P. DESJEUX, E. SCHWARTZ, B. BECK, AND C. HATZ. 2004. Treatment of cutaneous leishmaniasis among travellers. Journal of Antimicrobial Chemotherapy 53: 158-166.
7. BOYKIN, D. W., A. KUMAR, G. XIAO, W. D. WILSON, B. K. BENDER, D. R. MCCURDY, J. E. HALL, AND R. R. TIDWELL. 1998. 2,5-Bis-[4(N-alkylamidino)phenyl]furans as Pneumocystis carinii agents. Journal of Medicinal Chemistry 41: 124-129.
8. BRENDLE, J. J., A. OUTLAW, A. KUMAR, D. W. BOYKIN, D. A. PATRICK, R. R. TIDWELL, AND K. A. WERBOVETZ. 2002. Anti-leishmanial activities of several classes of aromatic dications. Antimicrobial Agents and Chemotherapy 46: 797-807.
9. CENTERS FOR DISEASE CONTROL AND PREVENTION. 2004. Update: Cutaneous leishmaniasis in US military personnel - Southwest/Central Asia, 2002-2004. MMWR Morbidity and Mortality Weekly Report 53: 264-265.
10. CROFT, S. L., K. SEIFERT, AND V. YARDLEY. 2006. Current scenario of drug development for leishmaniasis. Indian Journal of Medical Research 123: 399-410.
11. DAS, B., AND D. BOYKIN. 1977. Synthesis and antiprotozoal activity of 2,5-bis(4-guanylphenyl)furnas. Journal of Medicinal Chemistry 20: 531-563.
12. DESJEUX, P. 2004. Leishmaniasis: Current situation and new perspectives. Comparative Immunology, Microbiology and Infectious Diseases 27: 305-318.
13. FAULDE, M. K., G. HEYL, AND M. L. AMIRIH. 2006. Zoonotic cutaneous leishmaniasis, Afghanistan. Emerging Infectious Diseases 12: 1623-1624.
14. GONZALEZ, J. L., C. E. STEPHENS, T. WENZLER, R. BRUN, F. A. TANIOUS, W. D. WILSON, T. BARSZCZ, K. A. WERBOVETZ, AND D. W. BOYKIN. 2007. Synthesis and antiparasitic evaluation of bis-2,5-[4-guanidinophenyl] thiophenes. European Journal of Medicinal Chemistry 42: 552-557.
15. KAYSER, O., A. F. KIDERLEN, S. BERTELS, AND K. SIEMS. 2001. Antileishmanial activities of aphidicolin and its semisynthetic derivatives. Antimicrobial Agents and Chemotherapy 45: 288-292.
16. LINDSAY, D. S., B. L. BLAGBURN, J. E. HALL, AND R. R. TIDWELL. 1991. Activity of pentamidine and pentamidine analogs against Toxoplasma gondii in cell cultures. Antimicrobial Agents and Chemotherapy 35: 1914-1916.
17. _, N. S. RIPPEY, R. A. COLE, L. C. PARSONS, J. P. DUBEY, R. R. TIDWELL, AND B. L. BLAGBURN. 1994. Examination of the activities of 43 chemotherapeutic agents against Neospora caninum tachyzoites in cultured cells. American Journal of Veterinary Research 55: 976-981.
18. MATHIS, A. M., L. M. STURK, M. A. ISMAIL, D. W. BOYKIN, R. R. TIDWELL, AND J. E. HALL. 2006. Accumulation and intracellular distribution of antitrypanosomal diamidine compounds DB75 and DB820 in African trypanosomes. Antimicrobial Agents and Chemotherapy 50: 2185-2191.
19. MIKUS, J., AND D. STEVERDING. 2000. A simple colorimetric method to screen drug cytotoxicity against Leishmania using the dye Alamar Blue. Parasitology International 48: 265-269.
20. MISHRA, J., A. SAXENA, AND S. SINGH. 2007. Chemotherapy of leishmaniasis: Past, present, and future. Current Medicinal Chemistry 14: 1153-1169.
21. PATRICK, D., J. HALL, B. BENDER, D. MCCURDY, W. WILSON, F. TANIOUS, S. SAHA, AND R. TIDWELL. 1999. Synthesis and anti-Pneumocystis carinii pneumonia activity of novel dicationic dibenzothiophenes and diamidoxime prodrugs. European Journal of Medicinal Chemistry 34: 575-583.
22. RÄZ, B., M. ITEN, Y. GRETHER- BÜHLER, R. KAMINSKY, AND R. BRUN. 1997. The Alamar Blue® assay to determine drug sensitivity of African trypanosomes (T.b. rhodesiense and T.b. gambiense) in vitro. Acta Tropica 68: 139-147.
23. REITHINGER R., AND P. G. COLEMAN. 2007. Treating cutaneous leishmaniasis patients in Kabul, Afghanistan: Cost-effectiveness of an operational program in a complex emergency setting. BioMed Central Infectious Diseases 7: 3.
24. RIJAL, S., V. YARDLEY, F. CHAPPUIS, S. DECUYPERE, B. KHANAL, R. SINGH, M. BOELAERT, S. DE DONCKER, S. CROFT, AND J. C. DUJARDIN. 2007. Antimonial treatment of visceral leishmaniasis: Are current in vitro susceptibility assays adequate for prognosis of in vivo therapy outcome? Microbes and Infection 9: 529-535.
25. ROSYPAL, A. C., J. E. HALL, S. BAKUNOVA, D. A. PATRICK, S. BAKUNOV, C. E. STEPHENS, A. KUMAR, D. W. BOYKIN, AND R. R. TIDWELL. 2007. In vitro activity of dicationic compounds against a North American foxhound isolate of Leishmania infantum. Veterinary Parasitology 145: 207-216.
26. ROUSSEL, M., M. NACHER, G. FRÉMONT, B. ROTUREAU, E. CLYTI, D. SAINTE-MARIE, B. CARME, R. PRADINAUD, AND P. COUPPIÉ. 2006. Comparison between one and two injections of pentamidine isethionate, at 7 mg/kg in each injection, in the treatment of cutaneous leishmaniasis in French Guiana. Annals of Tropical Medicine and Parasitology 100: 307-314
27. ROWLAND, E. C., D. MOORE-LAI, J. R. SEED, C. E. STEPHENS, AND D. W. BOYKIN. 2003. Inhibition of in vitro intracellular growth of Trypanosoma cruzi by dicationic compounds. Journal of Parasitology 89: 1078-1080.
28. STEPHENS, C. E., R. BRUN, M. M. SALEM, K. A. WERBOVETZ, F. TAINOUS, W. D. WILSON, AND D. W. BOYKIN. 2003. The activity of diguanidino and 'reversed' diamidino 2,5-diarylfurans versus Trypanosoma cruzi and Leishmania donovani. Bioorganic and Medicinal Chemistry Letters 13: 2065-2069.
29. _, F. TANIOUS, S. KIM, W. D. WILSON, W. A. SCHELL, J. R. PERFECT, S. G. FRANZBLAU, AND D. W. BOYKIN. 2001. Diguanidino and 'reversed' diamidino 2,5-diarylfurans as antimicrobial agents. Journal of Medicinal Chemistry 44: 1741-1748.
30. WERBOVETZ, K. 2006. Diamidines as antitrypanosomal, antileishmanial, and antimalarial agents. Current Opinion in Investigational Drugs 7: 147-157.
31. _, J. J. BRENDLE, AND D. L. SACKETT. 1999. Purification, characterization, and drug susceptibility of tubulin from Leishmania. Molecular and Biochemical Parasitology 98: 53-65.
32. _, D. L. SACKETT, D. DELFÍN, G. BHATTACHARYA, M. SALEM, T. OBRZUT, D. RATTENDI, AND C. BACCHI. 2003. Selective antimicrotubule activity of N1-phenyl-3,5-dinitro-N4, N4-di-n-propylsulfanilamide (GB-11-5) against kinetoplastid parasites. Molecular Pharmacology 64: 1325-1333.
33. WILLARD, R. J., A. M. JEFFCOAT, P. M. BENSON, AND D. S. WALSH. 2005. Cutaneous leishmaniasis in soldiers from Fort Campbell, Kentucky returning from Operation Iraqi Freedom highlights diagnostic and therapeutic options. Journal of American Academy of Dermatology 52: 977-987.